Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why PAVmed Soared by 12% on Wednesday

TheMotleyFool

0 0

Why PAVmed Soared by 12% on WednesdayPhoto, wide shot, wide-angle lens, Medical device manufacturer, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/3a7f6312-1eee-4702-9005-93cc1e62f970.png

PAVmed (NASDAQ: PAVM) was a winner on Wednesday. The medical device maker's stock rose by over 12% on the back of a key appointment to the board of directors of its most important subsidiary.

That appointment is of Stanley Lapidus, the founder and onetime CEO of DNA-based diagnostics company Exact Sciences (NASDAQ: EXAS). Lapidus has been tapped to be vice chairman of the board of Lucid Diagnostics, the home of PAVmed's core suite of cancer testing products.

Image source: Getty Images.

Source Fool.com

Like: 0

EXAS

Share